Crossmark

Safety and efficacy of anti-CD30 CAR-T cell therapy in relapsed/refractory classic Hodgkin lymphoma: a systematic review and meta-analysis

Published Online: 2025-01-14

Authors

Meng, Fanqiao https://orcid.org/0000-0003-0174-2906
Xiang, Maoyuan

Liu, Yu

Zeng, Dongfeng
License Information

Text and Data Mining valid from 2025-01-14

Version of Record valid from 2025-01-14
More Information

Article History

Received: 1 December 2024

Accepted: 26 December 2024

First Online: 14 January 2025

Declarations

:

: Not applicable.

: Not applicable.

: The authors declare no competing interests.

Document is current